Anwendungen

This work describes the discovery of pre-existing binding and neutralising antibodies against SARS-CoV-2 in uninfected and unexposed individuals. These antibodies, likely induced by exposure to seasonal coronaviruses, are present in a small percent of adults but in the majority of children, consistent with the relative sparing of the latter from the severe form of COVID-19. In this study the Peptide Chemistry STP used our expertise and experience to firstly synthesise a set of peptide arrays to screen antibodies and following on from the array experiments, we synthesised a set of peptides for ELISA studies.